IRAE
Clinical trials for IRAE explained in plain language.
Never miss a new study
Get alerted when new IRAE trials appear
Sign up with your email to follow new studies for IRAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Gut-Targeting drug shield cancer patients from Immunotherapy's worst side effect?
Prevention Recruiting nowThis trial tests whether vedolizumab, a drug that calms inflammation in the gut, can prevent diarrhea and colitis caused by immune checkpoint inhibitors. People with advanced melanoma, lung, or kidney cancer who are starting immunotherapy and show early signs of gut inflammation …
Matched conditions: IRAE
Phase 2/3 • Sponsor: AHS Cancer Control Alberta • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Common nausea pill may tame immunotherapy's harsh side effects in liver cancer
Symptom relief Recruiting nowThis study tests whether ondansetron, a drug typically used for nausea, can lower the risk and severity of side effects from immunotherapy in people with liver cancer. About 134 patients will receive ondansetron alongside their standard cancer treatment. The goal is to see if thi…
Matched conditions: IRAE
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
New study aims to predict severe side effects in cancer immunotherapy
Knowledge-focused Recruiting nowThis study follows 200 adults with advanced cancer who are receiving immunotherapy. Researchers will track their physical and emotional distress, financial burden, care needs, and quality of life over one year. The goal is to develop a tool that can predict which patients are at …
Matched conditions: IRAE
Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC